Hjemdahl P - Search Results

1

Marked increase of fibrin gel permeability with very low dose ASA treatment.

Antovic A, Perneby C, Ekman GJ, Wallen HN, Hjemdahl P, Blombäck M, He S. Antovic A, et al. Among authors: hjemdahl p. Thromb Res. 2005;116(6):509-17. doi: 10.1016/j.thromres.2005.02.007. Thromb Res. 2005. PMID: 16181986

2

Dose- and time-dependent antiplatelet effects of aspirin.

Perneby C, Wallén NH, Rooney C, Fitzgerald D, Hjemdahl P. Perneby C, et al. Among authors: hjemdahl p. Thromb Haemost. 2006 Apr;95(4):652-8. Thromb Haemost. 2006. PMID: 16601836

3

Better increase in fibrin gel porosity by low dose than intermediate dose acetylsalicylic acid.

Williams S, Fatah K, Hjemdahl P, Blombäck M. Williams S, et al. Among authors: hjemdahl p. Eur Heart J. 1998 Nov;19(11):1666-72. doi: 10.1053/euhj.1998.1088. Eur Heart J. 1998. PMID: 9857919

4

Prothrombotic responses to exercise are little influenced by clopidogrel treatment.

Perneby C, Wallén NH, Hu H, Li N, Hjemdahl P. Perneby C, et al. Among authors: hjemdahl p. Thromb Res. 2004;114(4):235-43. doi: 10.1016/j.thromres.2004.06.004. Thromb Res. 2004. PMID: 15381386 Clinical Trial.

5

Platelet activity, coagulation, and fibrinolysis during exercise in healthy males: effects of thrombin inhibition by argatroban and enoxaparin.

Li N, He S, Blombäck M, Hjemdahl P. Li N, et al. Among authors: hjemdahl p. Arterioscler Thromb Vasc Biol. 2007 Feb;27(2):407-13. doi: 10.1161/01.ATV.0000253906.19648.ac. Epub 2006 Nov 30. Arterioscler Thromb Vasc Biol. 2007. PMID: 17138937 Clinical Trial.

6

Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease.

Perneby C, Wallén NH, Hofman-Bang C, Tornvall P, Ivert T, Li N, Hjemdahl P. Perneby C, et al. Among authors: hjemdahl p. Thromb Haemost. 2007 Dec;98(6):1316-22. doi: 10.1160/th07-05-0323. Thromb Haemost. 2007. PMID: 18064330 Clinical Trial.

7

A new assay for beta-thromboglobulin in urine.

Hjemdahl P, Perneby C, Theodorsson E, Egberg N, Larsson PT. Hjemdahl P, et al. Thromb Res. 1991 Oct 1;64(1):33-43. doi: 10.1016/0049-3848(91)90203-9. Thromb Res. 1991. PMID: 1837963

8

Optimization of an enzyme immunoassay for 11-dehydro-thromboxane B(2) in urine: comparison with GC-MS.

Perneby C, Granström E, Beck O, Fitzgerald D, Harhen B, Hjemdahl P. Perneby C, et al. Among authors: hjemdahl p. Thromb Res. 1999 Dec 15;96(6):427-36. doi: 10.1016/s0049-3848(99)00126-7. Thromb Res. 1999. PMID: 10632465 Clinical Trial.

9

Monitoring of coagulation factor therapy in patients with von Willebrand disease type 3 using a microchip flow chamber system.

Ågren A, Holmström M, Schmidt DE, Hosokawa K, Blombäck M, Hjemdahl P. Ågren A, et al. Among authors: hjemdahl p. Thromb Haemost. 2017 Jan 5;117(1):75-85. doi: 10.1160/TH16-06-0430. Epub 2016 Oct 20. Thromb Haemost. 2017. PMID: 27761577

10

Thromboxane metabolite excretion during pregnancy--influence of preeclampsia and aspirin treatment.

Perneby C, Vahter M, Akesson A, Bremme K, Hjemdahl P. Perneby C, et al. Among authors: hjemdahl p. Thromb Res. 2011 Jun;127(6):605-6. doi: 10.1016/j.thromres.2011.01.005. Epub 2011 Feb 12. Thromb Res. 2011. PMID: 21316743 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

393 results

Search Page

Filters